Annual EBITDA
-$20.28 M
-$669.00 K-3.41%
31 December 2023
Summary:
Traws Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$20.28 million, with the most recent change of -$669.00 thousand (-3.41%) on 31 December 2023. During the last 3 years, it has fallen by -$3.80 million (-23.06%). TRAW annual EBITDA is now -23.06% below its all-time high of -$16.48 million, reached on 01 December 2021.TRAW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$8.53 M
-$2.65 M-45.14%
30 September 2024
Summary:
Traws Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$8.53 million, with the most recent change of -$2.65 million (-45.14%) on 30 September 2024. Over the past year, it has dropped by -$3.45 million (-67.86%). TRAW quarterly EBITDA is now -221.97% below its all-time high of $7.00 million, reached on 01 September 2012.TRAW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$24.08 M
-$3.45 M-16.72%
30 September 2024
Summary:
Traws Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$24.08 million, with the most recent change of -$3.45 million (-16.72%) on 30 September 2024. Over the past year, it has dropped by -$2.53 million (-11.72%). TRAW TTM EBITDA is now -125.07% below its all-time high of -$10.70 million, reached on 01 March 2012.TRAW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRAW EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.4% | -67.9% | -11.7% |
| 3 y3 years | -23.1% | -127.0% | -46.1% |
| 5 y5 years | +6.5% | -49.1% | -11.0% |
TRAW EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.1% | at low | -127.0% | at low | -50.6% | at low |
| 5 y | 5 years | -23.1% | +18.8% | -127.0% | at low | -50.6% | +3.6% |
| alltime | all time | -23.1% | +68.0% | -222.0% | +57.3% | -125.1% | +65.4% |
Traws Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.53 M(+45.1%) | -$24.08 M(+16.7%) |
| June 2024 | - | -$5.88 M(+12.9%) | -$20.63 M(+6.6%) |
| Mar 2024 | - | -$5.21 M(+16.8%) | -$19.36 M(-4.6%) |
| Dec 2023 | -$20.28 M(+3.4%) | -$4.46 M(-12.3%) | -$20.28 M(-5.9%) |
| Sept 2023 | - | -$5.08 M(+10.4%) | -$21.55 M(-2.5%) |
| June 2023 | - | -$4.61 M(-24.9%) | -$22.11 M(+2.3%) |
| Mar 2023 | - | -$6.13 M(+7.1%) | -$21.62 M(+10.2%) |
| Dec 2022 | -$19.61 M(+19.0%) | - | - |
| Dec 2022 | - | -$5.73 M(+1.6%) | -$19.61 M(+11.2%) |
| Sept 2022 | - | -$5.64 M(+37.0%) | -$17.64 M(+10.3%) |
| June 2022 | - | -$4.12 M(-0.3%) | -$15.99 M(-3.2%) |
| Mar 2022 | - | -$4.13 M(+9.8%) | -$16.52 M(+0.2%) |
| Dec 2021 | -$16.48 M(-34.0%) | -$3.76 M(-5.7%) | -$16.48 M(-13.1%) |
| Sept 2021 | - | -$3.99 M(-14.1%) | -$18.97 M(-10.7%) |
| June 2021 | - | -$4.64 M(+13.3%) | -$21.26 M(-11.3%) |
| Mar 2021 | - | -$4.09 M(-34.5%) | -$23.95 M(-4.1%) |
| Dec 2020 | -$24.98 M(+15.2%) | -$6.25 M(-0.3%) | -$24.98 M(+2.2%) |
| Sept 2020 | - | -$6.27 M(-14.5%) | -$24.45 M(+5.0%) |
| June 2020 | - | -$7.34 M(+43.2%) | -$23.28 M(+18.9%) |
| Mar 2020 | - | -$5.12 M(-10.5%) | -$19.57 M(-9.7%) |
| Dec 2019 | -$21.68 M(-6.6%) | -$5.72 M(+12.4%) | -$21.69 M(-1.9%) |
| Sept 2019 | - | -$5.09 M(+40.2%) | -$22.10 M(-2.1%) |
| June 2019 | - | -$3.63 M(-49.8%) | -$22.58 M(-8.1%) |
| Mar 2019 | - | -$7.23 M(+17.9%) | -$24.57 M(+5.8%) |
| Dec 2018 | -$23.23 M | -$6.14 M(+10.0%) | -$23.23 M(+0.2%) |
| Sept 2018 | - | -$5.58 M(-0.8%) | -$23.19 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$5.63 M(-4.4%) | -$24.35 M(-1.7%) |
| Mar 2018 | - | -$5.89 M(-3.5%) | -$24.77 M(-3.4%) |
| Dec 2017 | -$25.65 M(+8.6%) | -$6.10 M(-9.5%) | -$25.65 M(-1.3%) |
| Sept 2017 | - | -$6.74 M(+11.4%) | -$26.00 M(+10.4%) |
| June 2017 | - | -$6.04 M(-10.7%) | -$23.55 M(+2.9%) |
| Mar 2017 | - | -$6.77 M(+5.0%) | -$22.88 M(-3.1%) |
| Dec 2016 | -$23.61 M(-0.9%) | -$6.45 M(+50.2%) | -$23.61 M(+69.5%) |
| Sept 2016 | - | -$4.29 M(-20.2%) | -$13.93 M(-10.1%) |
| June 2016 | - | -$5.38 M(-28.3%) | -$15.48 M(-18.7%) |
| Mar 2016 | - | -$7.50 M(-331.6%) | -$19.04 M(-20.1%) |
| Dec 2015 | -$23.82 M(-62.4%) | $3.24 M(-155.3%) | -$23.82 M(-40.9%) |
| Sept 2015 | - | -$5.85 M(-34.5%) | -$40.32 M(-18.2%) |
| June 2015 | - | -$8.93 M(-27.3%) | -$49.26 M(-13.6%) |
| Mar 2015 | - | -$12.28 M(-7.4%) | -$56.99 M(-10.0%) |
| Dec 2014 | -$63.31 M(+2.7%) | -$13.26 M(-10.3%) | -$63.31 M(-1.7%) |
| Sept 2014 | - | -$14.79 M(-11.3%) | -$64.38 M(-7.5%) |
| June 2014 | - | -$16.67 M(-10.4%) | -$69.58 M(+6.4%) |
| Mar 2014 | - | -$18.59 M(+29.7%) | -$65.38 M(+6.0%) |
| Dec 2013 | -$61.67 M(+193.9%) | -$14.33 M(-28.3%) | -$61.67 M(+7.2%) |
| Sept 2013 | - | -$19.98 M(+60.3%) | -$57.51 M(+88.4%) |
| June 2013 | - | -$12.46 M(-16.3%) | -$30.53 M(+21.3%) |
| Mar 2013 | - | -$14.89 M(+46.3%) | -$25.17 M(+20.0%) |
| Dec 2012 | -$20.98 M(-19.2%) | -$10.18 M(-245.4%) | -$20.98 M(+94.1%) |
| Sept 2012 | - | $7.00 M(-198.4%) | -$10.81 M(-39.3%) |
| June 2012 | - | -$7.11 M(-33.6%) | -$17.81 M(+66.4%) |
| Mar 2012 | - | -$10.70 M | -$10.70 M |
| Dec 2011 | -$25.96 M | - | - |
FAQ
- What is Traws Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Traws Pharma?
- What is Traws Pharma annual EBITDA year-on-year change?
- What is Traws Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Traws Pharma?
- What is Traws Pharma quarterly EBITDA year-on-year change?
- What is Traws Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Traws Pharma?
- What is Traws Pharma TTM EBITDA year-on-year change?
What is Traws Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TRAW is -$20.28 M
What is the all time high annual EBITDA for Traws Pharma?
Traws Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$16.48 M
What is Traws Pharma annual EBITDA year-on-year change?
Over the past year, TRAW annual earnings before interest, taxes, depreciation & amortization has changed by -$669.00 K (-3.41%)
What is Traws Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TRAW is -$8.53 M
What is the all time high quarterly EBITDA for Traws Pharma?
Traws Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $7.00 M
What is Traws Pharma quarterly EBITDA year-on-year change?
Over the past year, TRAW quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.45 M (-67.86%)
What is Traws Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TRAW is -$24.08 M
What is the all time high TTM EBITDA for Traws Pharma?
Traws Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$10.70 M
What is Traws Pharma TTM EBITDA year-on-year change?
Over the past year, TRAW TTM earnings before interest, taxes, depreciation & amortization has changed by -$2.53 M (-11.72%)